よむ、つかう、まなぶ。
参考１ (48 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00332.html |
| 出典情報 | 「新型コロナウイルス感染症（COVID－19）診療の手引き・第7.0版」の周知について（2／28付 事務連絡）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
●新型コロナウイルス感染症（COVID-19） 診療の手引き・第 7.0 版 ●４ 重症度分類とマネジメント
〈参考〉
・日本臨床救急医学会．新型コロナウイルス感染症流行期における発熱・呼吸器症状などを主訴とする患者の緊急度・重症度判定基準
（Version 1）について．2020.5．
・Maves RC, et al. Triage of scarce critical care resources in COVID-19 an implementation guide for regional allocation: An
expert panel report of the task force for mass critical care and the American College of Chest Physicians. Chest 2020.
・Sprung CL, et al. Adult ICU triage during the coronavirus disease 2019 Pandemic: Who will live and Who will die?
Recommendations to improve survival. Crit Care Med 2020.
・American College of Emergency Physicians. Emergency department COVID-19 management tool. 2021.
・Greenhalgh T, et al. What is the efficacy and safety of rapid exercise tests for exertional desaturation incovid-19? The
centre for evidence-based medicine (CEBM) 2020.
・Toussie D. Clinical and chest radiography features determine patient outcomes In young and middle age adults with
COVID-19, Radiology 2020.
・Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016.
・Kodama T, et al. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring
systems. J Infect Chemother 2021.
・Knight SR, et al. Risk stratification of patients admitted to hospital with Covid-19 using the ISARIC WHO clinical
characterisation protocol: development and validation of the 4C mortality score. BMJ 2020.
◆引用・参考文献◆
・伊藤正明，他．肺血栓塞栓症および深部静脈血栓症の診断，治療，予防に関するガイドライン（2017 年改訂版）
・厚生労働科学研究費補助金（新興・再興感染症及び予防接種政策推進研究事業）
「新興・再興感染症のリスク評価と危機管理機能の
実装のための研究」分担研究班 . COVID-19 急性呼吸不全への人工呼吸管理と ECMO 管理：基本的考え方 . 日本集中医誌 2020.
・日本環境感染学会．医療機関における新型コロナウイルス感染症への対応ガイド 第 4 版 , 2021.11.22.
・日本救急医学会，日本集中治療医学会．日本版敗血症診療ガイドライン 2020（J-SSCG2020）特別編，COVID-19 薬物療法に関
する Rapid/Living recommendations【第 4.2 版】2022.2.9．
・Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020.
・Barbaro RP, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the
extracorporeal life support organization registry. Lancet 2020.
・Barbaro RP, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international
Extracorporeal Life Support Organization Registry. Lancet 2021.
・Katagiri D, et al. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
J Clin
Apher 2021.
・Li J, et al. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 2020.
・Mozaffari E, et al.
Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in- hospital
all-cause mortality in a large multi-center observational cohort. Clin Infect Dis 2021.
・NIH. Coronavirus diseases 2019（COVID-19）treatment guidelines. 7 Feb 2022.
・Ronco C, et al. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Lancet Respir Med
2020.
・Sato R, et al. A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in
Japan. Glob Health Med 2020.
・Tachil J, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost
2020.
・WHO. COVID-19 Clinical management Living guidance. 23 Nov 2021.
・WHO. Corticosteroids for COVID-19. 2 September 2020.
・WHO. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts.
13 Aug 2020.
・Wong CKH, et al. Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered dexamethasone.
Clin Infect Dis 2021.
48
〈参考〉
・日本臨床救急医学会．新型コロナウイルス感染症流行期における発熱・呼吸器症状などを主訴とする患者の緊急度・重症度判定基準
（Version 1）について．2020.5．
・Maves RC, et al. Triage of scarce critical care resources in COVID-19 an implementation guide for regional allocation: An
expert panel report of the task force for mass critical care and the American College of Chest Physicians. Chest 2020.
・Sprung CL, et al. Adult ICU triage during the coronavirus disease 2019 Pandemic: Who will live and Who will die?
Recommendations to improve survival. Crit Care Med 2020.
・American College of Emergency Physicians. Emergency department COVID-19 management tool. 2021.
・Greenhalgh T, et al. What is the efficacy and safety of rapid exercise tests for exertional desaturation incovid-19? The
centre for evidence-based medicine (CEBM) 2020.
・Toussie D. Clinical and chest radiography features determine patient outcomes In young and middle age adults with
COVID-19, Radiology 2020.
・Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016.
・Kodama T, et al. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring
systems. J Infect Chemother 2021.
・Knight SR, et al. Risk stratification of patients admitted to hospital with Covid-19 using the ISARIC WHO clinical
characterisation protocol: development and validation of the 4C mortality score. BMJ 2020.
◆引用・参考文献◆
・伊藤正明，他．肺血栓塞栓症および深部静脈血栓症の診断，治療，予防に関するガイドライン（2017 年改訂版）
・厚生労働科学研究費補助金（新興・再興感染症及び予防接種政策推進研究事業）
「新興・再興感染症のリスク評価と危機管理機能の
実装のための研究」分担研究班 . COVID-19 急性呼吸不全への人工呼吸管理と ECMO 管理：基本的考え方 . 日本集中医誌 2020.
・日本環境感染学会．医療機関における新型コロナウイルス感染症への対応ガイド 第 4 版 , 2021.11.22.
・日本救急医学会，日本集中治療医学会．日本版敗血症診療ガイドライン 2020（J-SSCG2020）特別編，COVID-19 薬物療法に関
する Rapid/Living recommendations【第 4.2 版】2022.2.9．
・Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020.
・Barbaro RP, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the
extracorporeal life support organization registry. Lancet 2020.
・Barbaro RP, et al. Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international
Extracorporeal Life Support Organization Registry. Lancet 2021.
・Katagiri D, et al. Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
J Clin
Apher 2021.
・Li J, et al. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J 2020.
・Mozaffari E, et al.
Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in- hospital
all-cause mortality in a large multi-center observational cohort. Clin Infect Dis 2021.
・NIH. Coronavirus diseases 2019（COVID-19）treatment guidelines. 7 Feb 2022.
・Ronco C, et al. Coronavirus epidemic: preparing for extracorporeal organ support in intensive care. Lancet Respir Med
2020.
・Sato R, et al. A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in
Japan. Glob Health Med 2020.
・Tachil J, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost
2020.
・WHO. COVID-19 Clinical management Living guidance. 23 Nov 2021.
・WHO. Corticosteroids for COVID-19. 2 September 2020.
・WHO. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts.
13 Aug 2020.
・Wong CKH, et al. Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered dexamethasone.
Clin Infect Dis 2021.
48